ArticleAnalytical and bioanalytical chemistry2025
Dual microelectromembrane extraction as a tunable platform for the determination of antioxidant compounds with varied hydrophobicity in oral bioaccessibility assays of food commodities: a proof of concept.
Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
An automatic millifluidic dual microelectromembrane extraction (D-µEME) method as a front-end to HPLC-UV-Vis is herein proposed for the first time to facilitate the matrix clean-up of relatively polar polyphenolic acidic (PPA) antioxidants with a relatively broad range of lipophilicity (logP from -0.27 to 2.14) from simulated gastric extracts of oral bioaccessibility tests. The flow setup is amenable to handle microliter volumes of two distinct organic phases along with donor and acceptor phases unsupervised, conduct in-tube D-µEME in parallel without supporting membranes, and mix the two acceptor phases automatically prior to online HPLC-UV-Vis. The target antioxidants involve gallic acid, chlorogenic acid, 4-hydroxybenzoic acid, caffeic acid, and trans-cinnamic acid. Various solvents are explored to investigate their compatibility for simultaneous D-µEME, including 1-pentanol, 1-hexanol, 1-heptanol, 1-octanol, and 1-nonanol, as well as deep eutectic solvents, e.g., thymol/6-methyl coumarin, and ionic liquids as additives to alcohols. Notably, 1-pentanol and 1-octanol exhibit the best performances in extracting the most polar (gallic acid and chlorogenic acid) and the least polar analytes (trans-cinnamic acid), respectively, notwithstanding both solvents are amenable to retrieve analytes with medium hydrophobicity (4-hydroxybenzoic acid and caffeic acid). The effects of the voltage, the extraction time, and the sample ionic strength on the extraction recoveries are also investigated in detail. Under the selected D-µEME conditions, the overall linear ranges span from 1.25 to 80 mg/L, with limits of detection ranging from 0.2 to 3.3 mg/L. The flow-based D-µEME is resorted to oral bioaccessibility assays in the gastric phase of the target compounds from eggplant, blueberry, and coffee bean extracts, with relative extraction recoveries ranging from 71.5 to 133.5%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.